Bulgaria vs Oman: The number of people with susceptibility test result for rifampicin
Bulgaria
156
in 2021
Oman
144
in 2021
Bulgaria rank
100th
Oman rank
102nd
The number of people with susceptibility test result for rifampicin over time
- Bulgaria
- Oman
How they compare
Bulgaria currently reports 156 against 144 in Oman, a difference of 12.
That makes Bulgaria's figure about 1.1 times Oman's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Bulgaria ahead.
Bulgaria ranks 100th and Oman ranks 102nd of 155 countries.
Bulgaria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bulgaria | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 467.67 | 220.67 | 247 | Bulgaria |
| 2020s | 181.5 | 181 | 0.5 | Bulgaria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bulgaria or Oman?
- Bulgaria, at 156 against 144 in Oman as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bulgaria and Oman?
- 12, with Bulgaria ahead.
- How many years of comparable data are there for Bulgaria and Oman?
- 5 years are reported by both, from 2017 to 2021.
- How do Bulgaria and Oman rank globally for the number of people with susceptibility test result for rifampicin?
- Bulgaria ranks 100th and Oman ranks 102nd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.